Bartenschlager Lab – Group Members and Alumni

Group Mem­ber Posi­tion Room Phone Email
Prof. Dr. Ralf Bartenschlager Head of the Depart­ment Mol­e­c­u­lar Virology 104 +49 6221 56–4225 Ralf.Bartenschlager(at)med.uni-heidelberg.de
Maria del Pilar Milla AG Barten­schlager secretary 103 +49 6221 56–4225 Maria.Milla(at)med.uni-heidelberg.de
Dr. San­dra Bühler Sci­en­tif­ic coordination 107 +49 6221 56–7598 Sandra.Buehler(at)med.uni-heidelberg.de
Fredy Huschmand Con­trol­ling, Net­work Admin­is­tra­tion, Lab- Man­age­ment, Accounting 107 +49 6221 56–7895 Fredy.Huschman(at)med.uni-heidelberg.de
Dr. Katrin Woll Sci­en­tif­ic Coor­di­na­tor TRR179 1st floor +49 6221 56–34087 Katrin.Woll(at)med.uni-heidelberg.de
Dr. Ilka Rebhan Major ‘Infec­tious Dis­eases’, Doc­tor­al study pro­gramme, DZIF “Broad spec­trum antivi­rals” coordination 103 +49 6221 56–4225 Ilka.Rebhan(at)med.uni-heidelberg.de
Dr. Berati Cerikan Post­doc 102 +49 6221 56–4834 Berati.Cerikan(at)med.uni-heidelberg.de
Dr. Mirko Cortese Post­doc 102 +49 6221 56–4834 Mirko.Cortese(at)med.uni-heidelberg.de
Dr. Hong­bo Guo Post­doc 102 +49 6221 56–4834 Hongbo.Guo(at)med.uni-heidelberg.de
Dr. Sebas­t­ian Joecks Post­doc 102 +49 6221 56–4834 Sebastian.Joecks(at)med.uni-heidelberg.de
Dr. Ji Young Lee Post­doc 102 +49 6221 56–4834 JiYoung.Lee(at)med.uni-heidelberg.de
Dr. Pas­cal Mutz Post­doc 102 +49 6221 56–4834 Pascal.Mutz(at)med.uni-heidelberg.de
Dr. Christo­pher Neufeldt Post­doc 102 +49 6221 56–4834 Christopher.Neufeld(at)med.uni-heidelberg.de
Dr. Olga Oleksiuk Post­doc 102 +49 6221 56–4834 Olga.Oleksiuk(at)med.uni-heidelberg.de
Dr. Agniesz­ka Plociennikowska Post­doc 102 +49 6221 56–4834 Agnieszka.Plociennikowska(at)med.uni-heidelberg.de
Dr. Ste­fan Seitz Post­doc 102 +49 6221 56–4834 Stefan.Seitz(at)med.uni-heidelberg.de
Dr. Keisuke Tabata Post­doc 102 +49 6221 56–4834 Keisuke.Tabata(at)med.uni-heidelberg.de
Sung­min Eu PhD 102 +49 6221 56–4834 Sungmin.Eu(at)med.uni-heidelberg.de
Anna-Clara Franke PhD 102 +49 6221 56–4834 A.Franke(at)dfkz-heidelberg.de
Nadine Gillich PhD 102 +49 6221 56–4834 Nadine.Gillich(at)med.uni-heidelberg.de
Sarah Göll­ner PhD 102 +49 6221 56–4834 Sarah.Goellner(at)med.uni-heidelberg.de
Dominik Kiemel PhD 102 +49 6221 56–4834 Dominik.Kiemel(at)med.uni-heidelberg.de
Firat Nebioglu PhD 102 +49 6221 56–4834 Firat.Nebioglu(at)med.uni-heidelberg.de
Minh Tu Pham PhD 102 +49 6221 56–4834 MinhTu.Pham(at)med.uni-heidelberg.de
Anna Maria Plaszczyca PhD 102 +49 6221 56–4834 Anna.Plaszczyca(at)med.uni-heidelberg.de
Woan-Ing Twu PhD 102 +49 6221 56–4834 Woan-Ing.Two(at)med.uni-heidelberg.de
Lena Wer­stein Sci­en­tist 102 +49 6221 56–4834 Lena.Werstein(at)med.uni-heidelberg.de
Micha Fauth Lab­o­ra­to­ry technician 123 +49 6221 56–4834 Micha.Fauth(at)med.uni-heidelberg.de
Uta Hasel­mann Lab­o­ra­to­ry technician 102 +49 6221 56–4834 Uta.Haselmann(at)med.uni-heidelberg.de
Ulrike Her­ian Lab­o­ra­to­ry technician 125 +49 6221 56–4834 Ulrike.Herian(at)med.uni-heidelberg.de
Sabine Scholl Scullery staff 102 +49 6221 56–4834 Sabine.Scholl(at)med.uni-heidelberg.de

  • Gualtiero Alvisi (Assis­tant Pro­fes­sor in Micro­bi­ol­o­gy and Clin­i­cal Micro­bi­ol­o­gy, Uni­ver­si­ty of Pad­ua, Italy)
  • Silke Ben­der (Reg­u­la­to­ry Affairs Man­ag­er, Dr. Knoell Con­sult GmbH, Mannheim, Germany)
  • Lau­rent Cha­tel-Chaix (Assis­tant Pro­fes­sor, Insti­tut Nation­al de la Recherche Sci­en­tifique, Mon­tre­al, Canada)
  • Oliv­er Bauhofer (Prod­uct line Man­ag­er, Buch­er Biotec, Basel, Switzerland)
  • Car­o­la Berg­er (Com­pli­ance Inves­ti­ga­tor Man­u­fac­tur­ing, Novar­tis Oncol­o­gy, New Jer­sey, USA)
  • Abhi­lash Chi­ramel (Research Fel­low, Nation­al Insti­tute of Aller­gy and Infec­tious Dis­eases (NIAID), Hamil­ton, Mon­tana, USA)
  • Eva Daz­ert (Research Asso­ciate, Biozen­trum Basel, Switzerland)
  • Flo­ri­an Eber­le (BioN­Tech AG Mainz, Germany)
  • Wolf­gang Fis­chl (Head of Research, Hap­lo­gen GmbH, Vien­na, Austria)
  • Michael Frese (Health Research Insti­tute, Uni­ver­si­ty of Can­ber­ra, Australia)
  • Peter Friebe (Senior Direc­tor Appli­ca­tions and Cus­tomer Sup­port – US/EU, PlexBio Co., Ltd, San Fran­ciso, Cal­i­for­nia, USA)
  • Marie-Sophie Hiet (Region­al Sales Man­ag­er, Indi­vumed GmbH, Frank­furt am Main, Germany)
  • Vlas­tim­il Jirasko (Post­doc­tor­al Researcher, ETH, Zürich, Switzerland)
  • Stephanie Kallis
  • Artur Kaul (Ger­man Pri­mate Cen­ter, Göt­tin­gen, Germany)
  • Jan Krönke (Emmy Noe­ther Research Group, Uni­ver­si­ty Hos­pi­tal of Ulm, Germany)
  • Anil Kumar (Post­doc­tor­al Researcher, Uni­ver­si­ty of Alber­ta, Canada)
  • Gior­gos Kout­soudakis (Senior Sci­en­tist, Hos­pi­tal Clin­ic IDIBAPS, CIBERe­hd: Viral, tox­ic and meta­bol­ic hepatopahies Lab., Barcelona, Spain)
  • Gang Long (Pro­fes­sor, Prin­ci­pal Inves­ti­ga­tor, Insti­tut Pas­teur of Shang­hai, China)
  • Vane­sa Madan (Post­doc­tor­al Researcher, MRC Lab­o­ra­to­ry of Mol­e­c­u­lar Biol­o­gy (LMB), Cam­bridge, UK)
  • Andreas Merz (Glob­al Com­mer­cial Assess­ment Lead – Oncol­o­gy Busi­ness Devel­op­ment, Roche, Basel, Switzerland)
  • Philippe Metz (Study Man­ag­er Clin­i­cal Oper­a­tions, Roche Diag­nos­tics GmbH, Mannheim, Germany)
  • Sven Miller (Roche, Basel, Switzerland)
  • Thais Moraes (Sci­en­tif­ic Asso­ciate – EHS Mas­ter Data Man­age­ment, Dr. Knoell Con­sult GmbH, Mannheim, Germany)
  • Max Mün­ster (Asso­ciate Con­sul­tant, Bain & Com­pa­ny, Düs­sel­dorf, Germany)
  • Klaas Mul­der (Leader Tech­ni­cal Life­cy­cle Team, Glax­o­SmithK­line, Mar­burg, Germany)
  • David Paul (Post­doc­tor­al Researcher, MRC Lab­o­ra­to­ry of Mol­e­c­u­lar Biol­o­gy (LMB), Cam­bridge, UK)
  • Thomas Pietschmann (Full Pro­fes­sor and Direc­tor of the Insti­tute of Exper­i­men­tal Virol­o­gy, TWINCORE – Cen­tre for Exper­i­men­tal and Clin­i­cal Infec­tion Research, Han­nover, Germany)
  • Mar­i­on Poenisch (Cure­Vac, Tübin­gen, Germany)
  • Agnese Restuc­cia (Senior Med­ical Sci­en­tist Liv­er Dis­ease, Gilead Sci­ences, Rome, Italy)
  • Antje Reuter (Study Man­ag­er, Roche, Mannheim, Germany)
  • Ines Romero-Brey
  • Daniel Rupp (Uni­ver­si­ty Med­ical Cen­tre Mannheim, Germany)
  • Pietro Scatur­ro (Senior Research Sci­en­tist, Tech­ni­cal Uni­ver­si­ty Munich, Munich, Germany)
  • Torsten Schaller (Team leader preclinics/R&D, HDITX, Hei­del­berg, Germany)
  • Bian­ca Schmid (Prod­uct Man­ag­er, Behring, Hat­ter­sheim, Germany)
  • Anna Shavin­skaya (Head of the Office for Doc­tor­al Affairs, Med­ical Fac­ul­ty — Uni­ver­si­ty of Hei­del­berg, Germany)
  • Ina-Karen Stoeck (Asso­ciate Edi­tor — Neu­ro­sciences and Can­cer Research, Springer Ver­lag GmbH, Hei­del­berg, Germany)
  • Maud Tro­tard (Tech­ni­cal Appli­ca­tion Spe­cial­ist II, Ther­mofis­ch­er Sci­en­tif­ic, Darm­stadt, Germany)
  • Marc P. Windisch (Exec­u­tive Direc­tor Dis­cov­ery Biol­o­gy Divi­sion; Project Team Leader HBV drug dis­cov­ery, Insti­tute Pas­teur, Korea)
  • Tze­Feng Yong (Glob­al Reg­u­la­to­ry CMC Man­ag­er, Novar­tis Cell and Gene Ther­a­py, Basel, Switzerland)
  • Mar­gari­ta Zayas Lopez
  • Ulf Zeuge (Zuger Kan­ton­sspi­tal, Zug, Switzerland)